venlafaxine hydrochloride has been researched along with Abnormality, Heart in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrenstein, V; Kolding, L; Pedersen, L; Pedersen, LH; Petersen, OB; Sandager, P; Uldbjerg, N | 1 |
| Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H | 1 |
| Andersen, M; Furu, K; Haglund, B; Kieler, H; Nørgaard, M; Selmer, R; Zoëga, H | 1 |
| Berard, A; Ernest, SR; Hales, BF; Huang, C; Laurent, L; Vaillancourt, C | 1 |
| Wise, D | 1 |
| Bucak, İH; Çelik, M; Çevik, MÖ; Han Almış, B; Turğut, M | 1 |
1 review(s) available for venlafaxine hydrochloride and Abnormality, Heart
| Article | Year |
|---|---|
Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
Topics: Adult; Cohort Studies; Databases, Factual; Female; Heart Defects, Congenital; Humans; Middle Aged; Pregnancy; Pregnancy Outcome; Registries; Research Design; Risk Factors; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride; Ventricular Outflow Obstruction; Young Adult | 2016 |
5 other study(ies) available for venlafaxine hydrochloride and Abnormality, Heart
| Article | Year |
|---|---|
Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Denmark; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Prenatal Care; Prenatal Exposure Delayed Effects; Registries; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2021 |
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Topics: Adult; Cohort Studies; Contraindications; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Population Surveillance; Pregnancy; Pregnancy Complications; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Siblings; Venlafaxine Hydrochloride | 2015 |
In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
Topics: Administration, Oral; Animals; Female; Fetal Weight; Fetus; Fibroblast Growth Factor 8; Gene Expression; Heart; Heart Defects, Congenital; Litter Size; Male; Organ Size; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Venlafaxine Hydrochloride | 2016 |
Letter to the editor: Comments on venlafaxine paper by Laurent et al.
Topics: Animals; Female; Heart Defects, Congenital; Norepinephrine; Pregnancy; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2016 |
[Possible Relation Between Antenatal Venlafaxine Use and VACTERL Association in a Newborn: A Case Report].
Topics: Adult; Anal Canal; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Esophagus; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Kidney; Limb Deformities, Congenital; Pregnancy; Pregnancy Complications; Spine; Trachea; Venlafaxine Hydrochloride | 2017 |